Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
480 participants
OBSERVATIONAL
2014-10-31
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observing the Perioperative Effects of Prehabilitation in Colorectal Cancer Patients
NCT04762914
Functional Status and Quality of Life in Older Patients Undergoing Robotic Surgery for Colorectal Cancer
NCT05848609
Quality of Life After Enhanced Recovery Protocol for Colorectal Surgery
NCT02824783
Prehabilitation in Colorectal Cancer
NCT03096951
Quality of Recovery Using QoR-15 in Enhanced Recovery After Colorectal Surgery.
NCT04739605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
quality of care will be measured in the participating hospitals, using a retrospective patient record analysis
No interventions assigned to this group
Care Pathway
Care pathways for colorectal cancer
Care pathways for colorectal cancer
development of a care pathway for this patient group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Care pathways for colorectal cancer
development of a care pathway for this patient group
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Minimum age of 18 years;
3. Elective admission for colorectal cancer surgery
Exclusion Criteria
2. Patients with severe dementia (DSM IV) or severe concomitant disease that may affect very short-term outcome (life expectancy less than 3 months) and hence influence deviations from standard acute care.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
European Pathway Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Kris Vanhaecht
Professor in Healthcare Quality Management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kris Vanhaecht, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KULeuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
van Zelm R, Coeckelberghs E, Sermeus W, Wolthuis A, Bruyneel L, Panella M, Vanhaecht K. A mixed methods multiple case study to evaluate the implementation of a care pathway for colorectal cancer surgery using extended normalization process theory. BMC Health Serv Res. 2021 Jan 4;21(1):11. doi: 10.1186/s12913-020-06011-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP4NutriGICAN2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.